Literature DB >> 14642735

The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes.

Hans-Jörg Martin1, Frank Kornmann, Günter Fred Fuhrmann.   

Abstract

Flavonoids and isoflavonoids are potent inhibitors of glucose efflux in human erythrocytes. Net changes of sugars inside the cells were measured by right angle light scattering. The inhibitory potency of hydroxylated flavonoids depends on the pH of the medium. The apparent affinity is maximal at low pH where the molecule is in the undissociated form. The following K(i)-values at pH 6.5 in microM have been obtained: phloretin 0.37+/-0.03, myricetin 0.76+/-0.42, quercetin 0.93+/-0.28, kaempferol 1.33+/-0.17, isoliquiritigenin 1.96, genistein 3.92+/-0.62, naringenin 8.88+/-1.88, 7-hydroxyflavone 17.58+/-3.15 and daidzein 18.62+/-2.85. Flavonoids carrying hydroxyl groups are weak acids and are deprotonated at high pH-values. From spectral changes pK-values between 6.80 (naringenin) and 7.73 (myricetin) have been calculated. No such pK-value could be obtained from quercetin which was rather unstable at alkaline pH. Flavone itself without a hydroxyl group does not demonstrate any absorbance changes at different pH-values and no significant change in inhibition of glucose transport with pH (K(i)-value around 35 microM). In this respect it is similar to the antiestrogens diethylstilbestrol, tamoxifen and cyclofenil with K(i)-values for glucose efflux inhibition of 2.61+/-0.30, 6.75+/-2.03 and 3.97+/-0.54 microM. Except for phloretin, the flavonoids investigated have planar structures. The inhibitory activity in glucose efflux of planar flavonoids increases exponentially with the number of hydroxyl groups in the molecule.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642735     DOI: 10.1016/j.cbi.2003.06.001

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  20 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

2.  Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1.

Authors:  Kathryn E Hamilton; Janelle F Rekman; Leesha K Gunnink; Brianna M Busscher; Jordan L Scott; Andrew M Tidball; Nathan R Stehouwer; Grace N Johnecheck; Brendan D Looyenga; Larry L Louters
Journal:  Biochimie       Date:  2018-05-29       Impact factor: 4.079

3.  Anticancer agents interacting with membrane glucose transporters.

Authors:  C Granchi; S Fortunato; F Minutolo
Journal:  Medchemcomm       Date:  2016-07-08       Impact factor: 3.597

Review 4.  Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment.

Authors:  Collin M Labak; Paul Y Wang; Rishab Arora; Maheedhara R Guda; Swapna Asuthkar; Andrew J Tsung; Kiran K Velpula
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

Review 5.  A Review on Pharmacological and Analytical Aspects of Naringenin.

Authors:  Kanika Patel; Gireesh Kumar Singh; Dinesh Kumar Patel
Journal:  Chin J Integr Med       Date:  2014-12-10       Impact factor: 1.978

6.  Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules.

Authors:  Alexis Salas-Burgos; Pavel Iserovich; Felipe Zuniga; Juan Carlos Vera; Jorge Fischbarg
Journal:  Biophys J       Date:  2004-08-23       Impact factor: 4.033

Review 7.  Plant-derived glucose transport inhibitors with potential antitumor activity.

Authors:  Pratik Shriwas; Xiaozhuo Chen; A Douglas Kinghorn; Yulin Ren
Journal:  Phytother Res       Date:  2019-12-10       Impact factor: 5.878

8.  Identification of novel inhibitors of GLUT1 by virtual screening and cell-based assays.

Authors:  Xiaotong Chen; Yunshuo Zhao; Sifan Lyu; Guanfei Gao; Yanfeng Gao; Yuanming Qi; Jiangfeng Du
Journal:  Invest New Drugs       Date:  2021-04-26       Impact factor: 3.850

9.  Facilitated uptake of a bioactive metabolite of maritime pine bark extract (pycnogenol) into human erythrocytes.

Authors:  Max Kurlbaum; Melanie Mülek; Petra Högger
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

10.  A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models.

Authors:  Chrysi Xintaropoulou; Carol Ward; Alan Wise; Hugh Marston; Arran Turnbull; Simon P Langdon
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.